Saham Becton Dickinson (BDX)
NYSE · BDX
179.23
Fundamental
Market cap
$48.82B
Price / Earnings ratio
52.8x
Price / Sales ratio
2.4x
Price / Book ratio
2.0x
Return on assets
0.0%
Tanggal ex-dividen
9 Sep 2026
Tanggal pembayaran terakhir
30 Jun 2026
Jumlah dividen
$1.05
Dividend yield
2.3%
Rasio DER
0.7x
Berita terbaru
Tidak ada berita terbaru
Teknikal
OscillatorBuy5 Indikator
Moving AverageNeutral12 Indikator
Rating Analis
Strong Sell0
Sell0
Neutral5
Buy3
Strong Buy0
Financials
Performa
Pendapatan
Laba bersih
Net margin %
2021
2022
2023
2024
2025
26B17B9B0
Utang & Neraca
Total aset
Total liabilitas
2021
2022
2023
2024
2025
69B45B23B0
Pendapatan ke Laba
2025$21.8B
Pendapatan$0.0
Beban pokok$0.0
Laba kotor$0.0
Beban operasi$1.7B
Laba bersihEarnings
EPS forecast
Actual EPS
$3.68
$3.42
Q3FY25
$3.96
$3.91
Q4FY25
$2.91
$2.80
Q1FY26
$2.90
$2.77
Q2FY26
$3.23
$3.14
Q3FY26
The company reported results on Aug 05 2026 and beat market expectations.
Berita terbaru
Tidak ada berita terbaru
Tentang Becton Dickinson
Becton, Dickinson and Company, atau BD, adalah perusahaan teknologi medis global yang berfokus pada peningkatan penemuan medis, diagnostik, dan pemberian perawatan kesehatan. Portofolio produknya yang luas mencakup berbagai perangkat medis, seperti jarum suntik dan sistem infus, serta peralatan laboratorium dan solusi diagnostik canggih. Melalui inovasinya, BD memainkan peran penting dalam memerangi penyakit dan meningkatkan keselamatan pasien serta petugas kesehatan di seluruh dunia.
SektorHealthcare
IndustriMedical Instruments & Supplies
Karyawan72,000
CEOMr. Thomas E. Polen Jr.
Tanggal IPO1 Jan 1987
Kantor pusatFranklin Lakes, NJ
Eksekutif Utama
| Nama | Jabatan | Tahun Lahir |
|---|---|---|
| Mr. Thomas E. Polen Jr. | President, CEO & Chairman | 1973 |
| Dr. Michael D. Garrison | Executive VP & President of Medical Segment and BioPharma Systems Segments | 1970 |
| Mr. Michael C. Feld | Executive VP & Chief Revenue Officer | 1981 |
| Mr. Vitor Roque | Executive VP & CFO | 1983 |
| Ms. Elizabeth McCombs | Executive VP & CTO | 1977 |
| Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. | Senior VP & Chief Scientific Officer | — |
| Ms. Denise Russell Fleming | Executive Vice President & Chief Information Officer | 1971 |
| Mr. Shawn C. Bevec | Senior Vice President of Investor Relations | — |
| Ms. Lanesha T. Minnix J.D. | Executive VP & General Counsel | 1975 |
| Carla Burigatto | Senior VP & Chief Communications Officer | — |
Fundamental
Valuasi
Market cap$48.82B
Price-to-sales ratio2.39
Price-to-book value2.04
Price-earnings ratio52.80
Return on Equity5.00%
Return on Sales0.10%
Return on Assets0.02%
PEG ratio1.11
Earnings Per Share
Earnings Per Share$3.32
Income Statement
Average volume1,785,482
EBITDA$4.31B
1 year high (52w)$213.08
1 year low (52w)$140.11
Dividen
Tanggal ex-dividen9 Sep 2026
Jumlah dividen$1.05
Dividend yield2.34%
Tanggal pembayaran terakhir30 Jun 2026
Dividend yield (TTM)1.76%
Laporan laba berikutnyaN/A
Solvabilitas
Debt-to-equity ratio0.72
Teknikal
OscillatorBuy5 Indikator
Moving AverageNeutral12 Indikator
Kata para ahli
8 Rating Analis Wall Street
HOLD
38% Beli
63% Tahan
0% Jual
Target harga
$186.38
Est. imbal hasil
3.99%
Musiman
Perubahan harga bulanan (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.2 | -2.1 | -2.4 | +4.1 | ||||||||
| 2022 | +0.4 | +7.1 | -2.0 | -5.8 | +4.2 | -1.9 | -3.0 | +3.1 | -12.7 | +2.2 | +6.6 | +1.4 |
| 2023 | -1.5 | -7.7 | +6.6 | +7.0 | -8.9 | +6.4 | +6.4 | +0.3 | -7.2 | -1.9 | -6.9 | +2.3 |
| 2024 | -2.7 | -2.8 | +5.2 | -3.9 | -0.7 | -2.1 | +5.1 | +2.7 | -0.4 | -3.3 | -5.7 | +1.8 |
| 2025 | +9.3 | -8.9 | +0.3 | -8.4 | +1.8 | +1.7 | +0.3 | +9.4 | -0.5 | -6.4 | +9.4 | +1.2 |
| 2026 | +4.4 | -12.6 | -10.9 | -4.7 | -1.5 | +4.1 | +8.3 | +10.5 | -2.5 |
Aksi korporasi
Mendatang
DividenQ3/26
Tanggal ex-dividen9 Sep 2026
Tanggal bayar30 Sep 2026
Jumlah per saham$1.05
Sebelumnya
DividenQ2/26
Tanggal ex-dividen9 Jun 2026
Tanggal bayar30 Jun 2026
Jumlah per saham$1.05
DividenQ1/26
Tanggal ex-dividen10 Mar 2026
Tanggal bayar31 Mar 2026
Jumlah per saham$1.05
DividenQ4/25
Tanggal ex-dividen8 Des 2025
Tanggal bayar31 Des 2025
Jumlah per saham$1.05
DividenQ3/25
Tanggal ex-dividen8 Sep 2025
Tanggal bayar30 Sep 2025
Jumlah per saham$1.04
DividenQ2/25
Tanggal ex-dividen9 Jun 2025
Tanggal bayar30 Jun 2025
Jumlah per saham$1.04
DividenQ1/25
Tanggal ex-dividen10 Mar 2025
Tanggal bayar31 Mar 2025
Jumlah per saham$1.04
DividenQ4/24
Tanggal ex-dividen9 Des 2024
Tanggal bayar31 Des 2024
Jumlah per saham$1.04
DividenQ3/24
Tanggal ex-dividen9 Sep 2024
Tanggal bayar30 Sep 2024
Jumlah per saham$0.95
DividenQ2/24
Tanggal ex-dividen10 Jun 2024
Tanggal bayar28 Jun 2024
Jumlah per saham$0.95
DividenQ1/24
Tanggal ex-dividen7 Mar 2024
Tanggal bayar29 Mar 2024
Jumlah per saham$0.95
DividenQ4/23
Tanggal ex-dividen7 Des 2023
Tanggal bayar29 Des 2023
Jumlah per saham$0.95
DividenQ3/23
Tanggal ex-dividen7 Sep 2023
Tanggal bayar29 Sep 2023
Jumlah per saham$0.91
DividenQ2/23
Tanggal ex-dividen8 Jun 2023
Tanggal bayar30 Jun 2023
Jumlah per saham$0.91

